TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial November 10, 1989